CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
Crossref DOI link: https://doi.org/10.1186/s12885-015-1776-x
Published Online: 2015-10-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Melchardt, Thomas
Hufnagl, Clemens
Magnes, Teresa
Weiss, Lukas
Hutarew, Georg
Neureiter, Daniel
Schlattau, Alexander
Moser, Gerhard
Gaggl, Alexander
Tränkenschuh, Wolfgang
Greil, Richard
Egle, Alexander
License valid from 2015-10-16